About this trial
The PALMA project is part of a larger palliative research program COPAL in Capital Region of Denmark led by Professor Tom Møller. PALMA aims to improve palliative care for geriatric patients transitioning from emergency-hospital to primary care. The project addresses the lack of a systematic approach for assessing and managing palliative symptoms in geriatric patients to enhance communication between hospitals and municipal health care services.
The PALMA cohort investigates the applicability of systematic palliative assessment (EORTC-C15 PAL) in the geriatric emergency setting combined with measures of frailty, socio-demographic risks, and cross-sectoral healthcare support.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Patients in the geriatric emergency department are 65 years of age or older and referred by their own general practitioner or specialist for assessment and treatment of an acute medical problem. Approximately one-third are admitted and two-thirds are discharged to home facilities.
Trial design
Cohort
Prospective
Treatments tested in this trial
Prospective observational cohort study.
Other interventionNo systematic approach exists for symptom assessment, management, and reporting in delivered basic palliative care within the Danish healthcare system, implying considerable variation in hospital-based palliative care. The PALMA study consists of two superior phases divided in a development and an implementation stage that anchors basic palliative assessment and management within existing geriatric workflows and cross-sectoral collaborative care. The PALMA cohort will test the applicability of the EORTC-C15-PAL questionnaire along with measures of clinical frailty and sociodemographic risk factors. The development phase will enable the development of a clinical algorithm for elderly patients' need for cross-sectoral palliation care planning.
A prospective observational cohort study
Other interventionObservational design
Treatment groups
Trial outcomes
Primary outcomes
Mortality
Mortality rates at 3 and 6 months
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University Hospital Bispebjerg and Frederiksberg
Lead sponsor
The Danish Health Authority
Collaborator
This trial is not recruiting at the moment. You can still explore other options: